
Teaming up to tackle global health crises: Fibrosis
Kerstin Papenfuss, PhD, Director, Pharma, Deep Science Ventures, looks at the unmet need for fibrosis treatments and where drug discovery opportunities lay in terms of treatment and technology. Fibrosis is a complex pathological process characterised by excessive accumulation of extracellular matrix (ECM) components, particularly collagen, in response to chronic tissue… Read More















